Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrophage migration inhibitory factor and glucocorticoid sensitivity.

D Aeberli1, M Leech, E F Morand

  • 1Centre for Inflammatory Diseases, Monash Medical Centre, Locked Bag No 29, Clayton Melbourne 3168, Australia.

Rheumatology (Oxford, England)
|May 18, 2006
PubMed
Summary

Glucocorticoids (GCs) treat inflammatory diseases like rheumatoid arthritis (RA) but have side effects. Macrophage migration inhibitory factor (MIF) may regulate GC sensitivity and offers a target for steroid-sparing treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of a compulsory online compassion training module in final year medical student curriculum.

BMC medical education·2025
Same author

Outcomes and level of evidence in radiation therapy research and different categories of radiotherapy innovations: an ESTRO-VBRO bibliometrics analysis of the literature.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Building an appraisal framework for radiotherapy innovations in a value-based context: The ESTRO-Value-based radiation oncology categorisation system.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Influence of inter-observer delineation variability on radiomic features of the parotid gland.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2021
Same author

Geometric and Dosimetric Evaluation of a Commercially Available Auto-segmentation Tool for Gross Tumour Volume Delineation in Locally Advanced Non-small Cell Lung Cancer: a Feasibility Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Introduction to the ESTRO European Qualifications Framework (EQF) 7 and 8: Benchmarking Radiation Therapist (RTT) advanced education.

Technical innovations & patient support in radiation oncology·2020

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Glucocorticoids (GCs) are primary treatments for inflammatory conditions such as rheumatoid arthritis (RA).
  • GC therapy is linked to dose-dependent adverse effects.
  • Macrophage migration inhibitory factor (MIF) is implicated in modulating GC efficacy.

Purpose of the Study:

  • To review the pro-inflammatory role of MIF in RA.
  • To elucidate the intricate interactions between MIF and GCs.
  • To explore MIF as a potential target for steroid-sparing strategies in RA treatment.

Main Methods:

  • Literature review focusing on MIF's role in RA.
  • Analysis of studies detailing MIF-GC interactions.
  • Examination of emerging evidence on MIF as a therapeutic target.

Related Experiment Videos

Main Results:

  • MIF exhibits pro-inflammatory actions relevant to RA pathogenesis.
  • GCs can induce MIF, which in turn counteracts GC anti-inflammatory effects.
  • Evidence suggests MIF is a viable target for reducing GC dependency.

Conclusions:

  • MIF plays a significant role in RA inflammation and GC resistance.
  • Targeting MIF presents a promising avenue for developing steroid-sparing therapies.
  • Further research into MIF modulation could lead to improved RA management.